A detailed history of Berkeley Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 64,458 shares of PFE stock, worth $1.8 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
64,458
Previous 31,383 105.39%
Holding current value
$1.8 Million
Previous $903,000 98.01%
% of portfolio
0.55%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $856,311 - $983,319
33,075 Added 105.39%
64,458 $1.79 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $10,269 - $13,338
-393 Reduced 1.24%
31,383 $903,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $10,910 - $12,753
-340 Reduced 1.06%
31,776 $1.05 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $650 - $752
18 Added 0.06%
32,116 $1.18 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $419,542 - $546,183
-10,651 Reduced 24.92%
32,098 $1.31 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $18,578 - $24,252
-445 Reduced 1.03%
42,749 $2.19 Million
Q3 2022

Nov 04, 2022

BUY
$43.76 - $53.42 $19,341 - $23,611
442 Added 1.03%
43,194 $1.89 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $28,150 - $33,377
605 Added 1.44%
42,752 $2.24 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $8,372 - $10,374
183 Added 0.44%
42,147 $2.18 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $128,092 - $189,875
-3,100 Reduced 6.88%
41,964 $2.48 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $27,514 - $35,344
-701 Reduced 1.53%
45,064 $1.94 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $6,822 - $7,729
-190 Reduced 0.41%
45,765 $1.79 Million
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $7,334 - $8,271
219 Added 0.48%
45,955 $1.67 Million
Q4 2020

Jan 28, 2021

SELL
$33.47 - $42.56 $79,625 - $101,250
-2,379 Reduced 4.94%
45,736 $1.68 Million
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $189,515 - $222,345
-5,969 Reduced 11.04%
48,115 $1.77 Million
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $204,454 - $248,033
-6,788 Reduced 11.15%
54,084 $1.77 Million
Q1 2020

Apr 21, 2020

BUY
$27.03 - $38.62 $651,179 - $930,394
24,091 Added 65.5%
60,872 $1.99 Million
Q4 2019

Jan 24, 2020

SELL
$32.92 - $37.36 $68,276 - $77,484
-2,074 Reduced 5.34%
36,781 $1.44 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $25,147 - $32,608
-774 Reduced 1.95%
38,855 $1.4 Million
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $702 - $788
19 Added 0.05%
39,629 $1.72 Million
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $72,862 - $80,051
1,943 Added 5.16%
39,610 $1.68 Million
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $52,819 - $60,219
-1,373 Reduced 3.52%
37,667 $1.64 Million
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $261,868 - $317,630
-7,597 Reduced 16.29%
39,040 $1.72 Million
Q2 2018

Aug 07, 2018

SELL
$32.98 - $35.16 $10,553 - $11,251
-320 Reduced 0.68%
46,637 $1.69 Million
Q1 2018

Apr 27, 2018

BUY
$31.91 - $37.02 $401,938 - $466,303
12,596 Added 36.66%
46,957 $1.67 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $28,803 - $30,561
866 Added 2.59%
34,361 $1.25 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $1.04 Million - $1.14 Million
33,495
33,495 $1.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Berkeley Capital Partners, LLC Portfolio

Follow Berkeley Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.